Phase II study of pegylated liposomal doxorubicin (Caelyx&unknown;) as induction chemotherapy for patients with squamous cell cancer of the head and neck

By Harrington K.J.   Lewanski C.   Northcote A.D.   Whittaker J.   Peters A.M.   Vile R.G.   Stewart J.S.W.  

European Journal of Cancer, Vol. 37, Iss. 16, 2001-11 ,pp. : 2015-2022

Elsevier

Access to resources Recommend Favorite

Randomized phase III trial of pegylated liposomal doxorubicin versus vinorelbine or mitomycin C plus vinblastine in women with taxane-refractory advanced breast cancer

By Garcia Agustin  

The Women's Oncology Review, Vol. 5, Iss. 1, 2005-03 ,pp. : 49-51

Informa Healthcare

Access to resources Recommend Favorite

Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL(R)/CAELYX(R)) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma - a study by the EORTC Soft Tissue and Bone Sarcoma Group

By Judson I.   Radford J.A.   Harris M.   Blay J.-Y.   van Hoesel Q.   le Cesne A.   van Oosterom A.T.   Clemons M.J.   Kamby C.   Hermans C.   Whittaker J.   Donato di Paola E.   Verweij J.   Nielsen S.  

European Journal of Cancer, Vol. 37, Iss. 7, 2001-05 ,pp. : 870-877

Elsevier

Access to resources Recommend Favorite

Salvage chemotherapy with docetaxel and pegylated liposomal doxorubicin in pretreated patients with platinum- and taxane-sensitive ovarian cancer: a multicenter phase II trial of the Hellenic Oncology Research Group (HORG)

By Koinis Filippos   Polyzos Aristidis   Christopoulou Athina   Zafeiriou Zafeiris   Emmanouilidis Christos   Papadimitraki Elisavet   Kalykaki Antonia   Kalbakis Kostas   Samonis George   Georgoulias Vassilis  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 4, 2014-04 ,pp. : 819-825

Springer Publishing Company

Access to resources Recommend Favorite

Phase II clinical trial with pegylated liposomal doxorubicin

By Poveda A.  

Sarcoma, Vol. 9, Iss. 3-4, 2005-09 ,pp. : 127-132

Informa Healthcare

Access to resources Recommend Favorite